Clinical Trials Directory

Trials / Completed

CompletedNCT04943276

A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome

A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators hope to learn the feasibility and preliminary efficacy of the Embr device for improving thermal comfort in individuals with POTS and impaired thermoregulation. Feasibility will be assessed via usage of the Embr device and participant feedback. Preliminary efficacy measures will include temperature-related symptoms and temperature- related quality of life in individuals with POTS and impaired thermoregulation.

Conditions

Interventions

TypeNameDescription
DEVICEEmbr DeviceThe Embr thermal device will be worn at all times from study start to the study endpoint.

Timeline

Start date
2022-02-27
Primary completion
2023-11-03
Completion
2023-11-03
First posted
2021-06-29
Last updated
2024-10-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04943276. Inclusion in this directory is not an endorsement.

A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome (NCT04943276) · Clinical Trials Directory